Navigation Links
Fatherhood linked to prostate cancer risk
Date:1/6/2008

A new study from Danish researchers has found that childless men have a lower risk of developing prostate cancer than fathers, and that, paradoxically, the more children a father has, the lower the risk of the disease. The study appears in the February 15, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Whether fatherhood can affect the risk of prostate cancer remains controversial. Evidence has suggested that childless men may be at lower risk of prostate cancer than men with children, and that men who father sons may be at lower risk than men with daughters only. To address the issue, researchers led by Kristian Jrgensen of the Statens Serum Institut, in Copenhagen, Denmark, used a national population-based register to analyze data from all men born in Denmark between 1935 and 1988, among which 3,400 developed prostate cancer. They found men without children were 16 percent less likely than those with children to be diagnosed with prostate cancer during up to 35-years of follow up. The analysis also revealed that among fathers, there was a gradually reduced prostate cancer risk with increasing number of children. The authors suggest that, theoretically, this might reflect a healthy father phenomenon, in which men who retain fertility are less likely to develop a malignancy. The study found no association between prostate risk and child gender.

The analysis did not reveal what factors associated with childlessness might be responsible for the risk reduction. Currently known risk factors for prostate cancer are race, family history of prostate cancer, and advanced age. Regardless of the underlying mechanism, the results of the current study provide prospective, epidemiologic support for the view that childless men are somehow at lower risk of developing prostate cancer, the authors wrote.

The authors also note that additional studies are required to identify the underlying biologic, environmental, social
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Farming, Fatherhood Hallmarks of Men Who Live to 100
2. Health Department Warns Consumers of Home-Canned Soup Linked to Potter County Restaurant
3. Obesity linked to decreased seatbelt use
4. High Blood Triglycerides Linked to Stroke Risk
5. Omega-3s Linked to Prevention of Parkinsons Disease and More
6. Mental health linked to amputation risk in diabetic veterans
7. Insurance status linked to cancer outcomes
8. Severe Psoriasis Linked to Higher Death Risk
9. Study: Short sleep times in patients with chronic medical diagnoses linked to obesity
10. Study finds gene linked to aggressive prostate cancer
11. High Meat Consumption Linked to Heightened Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 1Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 1ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 3ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 4ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 5ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 6ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 7ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 8ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 9ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 10ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 11